These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 39201075)
41. Is There a Correlation between New Scoring Systems and Systemic Inflammation in Stable Bronchiectasis? Coban H; Gungen AC Can Respir J; 2017; 2017():9874068. PubMed ID: 29270068 [TBL] [Abstract][Full Text] [Related]
42. Correlation of fractional exhaled nitric oxide (FeNO) and clinical outcomes in patients with chronic obstructive pulmonary disease: A prospective cohort study. Keeratichananont W; Kaenmuang P; Geater SL; Denyuk R; Kanchanakanok C Respir Med; 2024 May; 229():107682. PubMed ID: 38815659 [TBL] [Abstract][Full Text] [Related]
43. Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis. Bekir M; Kocakaya D; Balcan B; Olguz Yıldızeli Ş; Eryüksel E; Ceyhan B Tuberk Toraks; 2020 Jul; 68(2):103-111. PubMed ID: 32755109 [TBL] [Abstract][Full Text] [Related]
44. Hiatal hernias are correlated with increased severity of non-cystic fibrosis bronchiectasis. McDonnell MJ; Ahmed M; Das J; Ward C; Mokoka M; Breen DP; O'Regan A; Gilmartin JJ; Bruzzi J; Rutherford RM Respirology; 2015 Jul; 20(5):749-57. PubMed ID: 25872951 [TBL] [Abstract][Full Text] [Related]
45. Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes. McDowell PJ; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker S; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan D; Mansur AH; Fowler SJ; Diver SE; Howarth P; Lordan J; Menzies-Gow A; Harrison T; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID; Heaney LG Am J Respir Crit Care Med; 2022 Sep; 206(5):545-553. PubMed ID: 35549845 [No Abstract] [Full Text] [Related]
46. Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis. Jeong JH; Heo M; Kim EJ; Hah YS; Heo IR; Kim TH; Kim HC; Ju S; Yoo JW; Jeong YY; Lee JD; Lee SJ Respir Med; 2021; 185():106505. PubMed ID: 34139579 [TBL] [Abstract][Full Text] [Related]
47. Presence and sequence of bronchiectasis onset impact on the clinical characteristics in asthmatic patients. Sheng H; Wang Y; Yao X; Zhang X; Wang X; Liu X; Zhang L J Thorac Dis; 2023 Jun; 15(6):3025-3047. PubMed ID: 37426162 [TBL] [Abstract][Full Text] [Related]
48. The association between serum albumin/prealbumin level and disease severity in non-CF bronchiectasis. Li L; Li Z; Bi J; Li H; Wang S; Shao C; Song Y Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1537-1544. PubMed ID: 32347970 [TBL] [Abstract][Full Text] [Related]
49. Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity. Martinez-Garcia MÁ; Athanazio R; Gramblicka G; Corso M; Cavalcanti Lundgren F; Fernandes de Figueiredo M; Arancibia F; Rached S; Girón R; Máiz Carro L; de la Rosa Carrillo D; Prados C; Olveira C Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):81-87. PubMed ID: 30119935 [TBL] [Abstract][Full Text] [Related]
50. Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study. Sheng H; Yao X; Wang X; Wang Y; Liu X; Zhang L BMC Pulm Med; 2021 Jul; 21(1):211. PubMed ID: 34225679 [TBL] [Abstract][Full Text] [Related]
51. Impact of asthma on bronchiectasis severity and risk of exacerbations. Ferri S; Crimi C; Campisi R; Cacopardo G; Paoletti G; Puggioni F; Crimi N; Heffler E J Asthma; 2022 Mar; 59(3):469-475. PubMed ID: 33256490 [TBL] [Abstract][Full Text] [Related]
52. Chronic Bacterial Infection Prevalence, Risk Factors, and Characteristics: A Bronchiectasis Population-Based Prospective Study. Amorim A; Meira L; Redondo M; Ribeiro M; Castro R; Rodrigues M; Martins N; Hespanhol V J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30845638 [TBL] [Abstract][Full Text] [Related]
53. Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis. Dente FL; Bilotta M; Bartoli ML; Bacci E; Cianchetti S; Latorre M; Malagrinò L; Nieri D; Roggi MA; Vagaggini B; Paggiaro P Mediators Inflamm; 2015; 2015():642503. PubMed ID: 26819500 [TBL] [Abstract][Full Text] [Related]
54. Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma. Afriyie-Mensah JS; Domoyeri P; Antwi-Boasiako C; Aryee R; Dankwah GB; Ntiamoah M; Dzudzor B; Kusi-Mensah Y; Hayfron-Benjamin CF Ann Med; 2024 Dec; 56(1):2382377. PubMed ID: 39051101 [TBL] [Abstract][Full Text] [Related]
55. Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study. Shoemark A; Shteinberg M; De Soyza A; Haworth CS; Richardson H; Gao Y; Perea L; Dicker AJ; Goeminne PC; Cant E; Polverino E; Altenburg J; Keir HR; Loebinger MR; Blasi F; Welte T; Sibila O; Aliberti S; Chalmers JD Am J Respir Crit Care Med; 2022 Apr; 205(8):894-902. PubMed ID: 35050830 [No Abstract] [Full Text] [Related]
56. Exhaled nitric oxide levels to guide treatment for adults with asthma. Petsky HL; Kew KM; Turner C; Chang AB Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011440. PubMed ID: 27580628 [TBL] [Abstract][Full Text] [Related]
57. Eosinophilic bronchiectasis increases length and cost of hospitalization: a retrospective analysis in a hospital of southern China from 2012 to 2020. Lei C; Zeng Z; Chen F; Guo Y; Liu Y BMC Pulm Med; 2024 Feb; 24(1):98. PubMed ID: 38408986 [TBL] [Abstract][Full Text] [Related]
58. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for the development of bronchiectasis in patients with asthma. Ma D; Cruz MJ; Ojanguren I; Romero-Mesones C; Varona-Porres D; Munoz X Sci Rep; 2021 Nov; 11(1):22820. PubMed ID: 34819607 [TBL] [Abstract][Full Text] [Related]
60. Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study. Abdo M; Watz H; Veith V; Kirsten AM; Biller H; Pedersen F; von Mutius E; Kopp MV; Hansen G; Waschki B; Rabe KF; Trinkmann F; Bahmer T Respir Res; 2020 Oct; 21(1):278. PubMed ID: 33087134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]